The Down Syndrome-Associated Protein, Regulator of Calcineurin-1, is Altered in Alzheimer’s Disease and Dementia with Lewy Bodies
Open Access
- 6 March 2019
- journal article
- Published by Intellectual Consortium of Drug Discovery and Technology Development Incorporation
Abstract
There is a known relationship between Alzheimer’s disease (AD) and Down syndrome (DS), with the latter typically developing AD-like neuropathology in mid-life. In order to further understand this relationship we examined intersectin-1 (ITSN1) and the regulator of calcineurin-1 (RCAN1), proteins involved in endosomal and lysosomal trafficking that are over-expressed in DS. We examined RCAN1 and ITSN1 levels (both long (-L) and short (-S) isoforms) and the level of endogenous metals in White Blood Cells (WBCs) collected from AD patients who were enrolled in the Australian Imaging, Biomarker and Lifestyle Study on Ageing (AIBL). We also examined RCAN1 and ITSN1-S and -L in post-mortem brain tissue in a separate cohort of patients with AD or other types of dementia including Dementia with Lewy Bodies (DLB) and non-Alzheimer’s disease dementia. We found that RCAN1 was significantly elevated in AD and DLB brain compared with controls, but there was no difference in the level of RCAN1 in WBCs of AD patients. There were no differences in the levels of ITSN1-L and −S between AD and the control, nor between other types of dementia and the control. We found that there were no differences in the levels of metals between AD and the control WBCs. In conclusion, our data demonstrate that RCAN1 is differentially regulated between the peripheral and central compartments in AD and should be further investigated to understand its potential role in dementia of AD and DLB.This publication has 28 references indexed in Scilit:
- Translational gene mapping of cognitive declineNeurobiology of Aging, 2008
- Alzheimer's disease and endocytic dysfunction: Clues from the Down syndrome-related proteins, DSCR1 and ITSN1Ageing Research Reviews, 2006
- Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's diseaseJournal of Alzheimer's Disease, 2005
- Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseasesNeurobiology of Aging, 2005
- Alzheimer’s disease—a sum greater than its parts?Neurobiology of Aging, 2004
- Traffic at the intersection of neurotrophic factor signaling and neurodegenerationTrends in Neurosciences, 2003
- Chronic Overexpression of the Calcineurin Inhibitory Gene DSCR1 (Adapt78)Is Associated with Alzheimer's DiseaseOnline Journal of Public Health Informatics, 2001
- Endocytic Pathway Abnormalities Precede Amyloid β Deposition in Sporadic Alzheimer’s Disease and Down SyndromeThe American Journal of Pathology, 2000
- Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic miceProceedings of the National Academy of Sciences of the United States of America, 2000
- Antibodies to ?-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's diseaseAnnals of Neurology, 1999